A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK-Abello A/S, Originator or ALK HDM Tablets in Adult Subjects With Allergic Rhinitis and/or Atopic Asthma Induced by House Dust Mites (HDM)

Conditions: Allergy; Asthma; Rhinitis
Interventions: Drug: Mitizax; Drug: Placebo
Sponsors: Abbott; Linical Co., Ltd; Datamap
Recruiting – verified November 2015